Skip to main content

2021

Articles

13 May 2021

9 ways we can make it easier for Australians to get the COVID-19 vaccine

There are tangible things we can do now to help people understand the benefits and possible risks of COVID-19 vaccination, and get the vaccine quickly as soon as they’re eligible.
11 May 2021

Grant success for MBI researcher in the PhD partnership program

Associate Professor Julianne Djordevic’s project entitled Developing inhibitors of fungal inositol polyphosphate kinases as a novel class of antifungal drug , has been funded ,and will allow her PhD student Desmarini Desmarini to work alongside industry partner, Biodiem, a subsidiary of Opal Biosciences Australia, who will provide mentoring and engagement with external industry.
15 April 2021

MBI announced as Flagship Centre

As part of their 2025 Strategy, the Faculty of Medicine and Health embarked on a review of its Research Centres to determine where they should strategically focus their research support and investment.
15 April 2021

Cryptococcal Antigen in Serum and Cerebrospinal Fluid for Detecting Cryptococcal Meningitis in Adults Living With Human Immunodeficiency Virus: Systematic Review and Meta-Analysis of Diagnostic Test Accuracy Studies

Cryptococcal meningitis (CM), a life-threatening systemic, opportunistic fungal infection, occurs mainly in patients with defective cellular immunity. Cryptococcal antigen (CrAg) detection could direct the timely initiation of antifungal therapy.
14 April 2021

Active case‐finding in contacts of people with TB

Exposure to people with TB substantially elevates a person’s risk of tuberculous infection and TB disease. Systematic screening of TB contacts enables the early detection and treatment of co-prevalent disease, and the opportunity to prevent future TB disease.
14 April 2021

Determining the value of TB active case-finding: current evidence and methodological considerations

Active case-finding (ACF) is an important component of the End TB Strategy. However, ACF is resource-intensive, and the economics of ACF are not well-understood. Research is essential to the optimal implementation, cost-effectiveness, and affordability of ACF in high-burden settings.
14 April 2021

Epidemiology of Healthcare-Associated Infections in Australia

This is Australia’s first peer-reviewed evidence-based assessment of the epidemiology of HAIs using publicly available data from hospital-acquired complications (HACs) state-based surveillance systems and peer-reviewed and grey literature sources.
14 April 2021

The Model Crisis, or how to have critical promiscuity in the time of Covid-19

During the past forty years, statistical modelling and simulation have come to frame perceptions of epidemic disease and to determine public health interventions that might limit or suppress the transmission of the causative agent. The influence of such formulaic disease modelling has pervaded public health policy and practice during the Covid-19 pandemic.
24 March 2021

Addressing the neglected global burden of child and drug-resistant tuberculosis

Australia’s National Health and Medical Research Council has launched the 12th edition of 10 of the Best, showcasing significant projects that support the improvement of human health.
24 March 2021

Zoonotic Tuberculosis – The Changing Landscape 

Despite slow reductions in the annual burden of active human tuberculosis (TB) cases, zoonotic TB (zTB) remains a poorly monitored and an important unaddressed global problem.